• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

斑马鱼作为探索心血管疾病发病机制和新型治疗干预措施的创新模型:分子见解。

Zebrafish as an innovative model for exploring cardiovascular disease induction mechanisms and novel therapeutic interventions: a molecular insight.

机构信息

Medical Toxicology and Biochemistry Laboratory, Department of Zoology, Government College University, Lahore, 54000, Pakistan.

出版信息

Mol Biol Rep. 2024 Aug 12;51(1):904. doi: 10.1007/s11033-024-09814-w.

DOI:10.1007/s11033-024-09814-w
PMID:39133413
Abstract

Cardiovascular disease (CVD) is a common cardiac disorder that leads to heart attacks, strokes, and heart failure. It is primarily characterized by conditions that impact the heart and blood arteries, including peripheral artery disease, arrhythmias, atherosclerosis, myocardial ischemia, congenital heart abnormalities, heart failure, rheumatic heart disease, hypertension, and cardiomyopathies. These conditions are mainly effect the heart and blood vessels, causing blockages or weakened pumping, due to severe hereditary and environmental factors. The frequency of CVD is rising significantly as life expectancy increases. Despite this, no effective treatment or management for its symptoms has been found. One of the most difficult obstacles to overcome, is finding a suitable animal model for drug screening and drug development. Although rodents, mice, swine, and mammals serve as the basis for most animal models of cardiovascular disease, no model accurately captures the epidemiology of the condition. Zebrafish (Danio rerio) have drawn the interest of the international scientific community due to certain shortcomings of the previously discussed animal models because they are smaller, less costly, and have an incredibly high rate of reproduction. This review article emphasizes the significance of using zebrafish as an animal model to investigate the possible facets of cardiovascular disease. Moreover, the ultimate purpose of this review article is to establish the advantages of employing zebrafish over other animal models and to investigate the boundaries of using zebrafish to study human disease. Furthermore, the mechanisms of cardiovascular diseases induction in zebrafish were covered to improve understanding for readers. Finally, the analysis of cardiotoxicity using Zebra fish model, is also explained. In order to stop the health index from deteriorating, the current study also covers some innovative, effective, and relatively safer treatments for treatment and management of cardiotoxicity.

摘要

心血管疾病(CVD)是一种常见的心脏疾病,可导致心脏病发作、中风和心力衰竭。它主要表现为影响心脏和动脉的疾病,包括外周动脉疾病、心律失常、动脉粥样硬化、心肌缺血、先天性心脏异常、心力衰竭、风湿性心脏病、高血压和心肌病。这些疾病主要影响心脏和血管,导致严重的遗传和环境因素引起的阻塞或泵血功能减弱。随着预期寿命的延长,心血管疾病的发病率显著上升。尽管如此,尚未发现针对其症状的有效治疗或管理方法。其中一个最困难的障碍是为药物筛选和药物开发找到合适的动物模型。尽管啮齿动物、老鼠、猪和哺乳动物是大多数心血管疾病动物模型的基础,但没有一种模型能准确捕捉到该疾病的流行病学特征。斑马鱼(Danio rerio)由于先前讨论的动物模型存在某些缺点而引起了国际科学界的兴趣,因为它们体积更小、成本更低,并且具有极高的繁殖率。这篇综述文章强调了使用斑马鱼作为动物模型来研究心血管疾病可能方面的重要性。此外,本文的最终目的是确立使用斑马鱼相对于其他动物模型的优势,并探讨使用斑马鱼研究人类疾病的局限性。此外,还涵盖了在斑马鱼中诱导心血管疾病的机制,以帮助读者更好地理解。最后,还解释了使用斑马鱼模型进行心脏毒性分析。为了阻止健康指数恶化,目前的研究还涵盖了一些创新、有效和相对更安全的治疗方法,用于治疗和管理心脏毒性。

相似文献

1
Zebrafish as an innovative model for exploring cardiovascular disease induction mechanisms and novel therapeutic interventions: a molecular insight.斑马鱼作为探索心血管疾病发病机制和新型治疗干预措施的创新模型:分子见解。
Mol Biol Rep. 2024 Aug 12;51(1):904. doi: 10.1007/s11033-024-09814-w.
2
Zebrafish models of cardiovascular disease.心血管疾病的斑马鱼模型。
Heart Fail Rev. 2016 Nov;21(6):803-813. doi: 10.1007/s10741-016-9579-y.
3
Fishing for the genetic basis of cardiovascular disease.探寻心血管疾病的遗传基础。
Dis Model Mech. 2009 Jan-Feb;2(1-2):18-22. doi: 10.1242/dmm.000687.
4
Zebrafish as a tractable model of human cardiovascular disease.斑马鱼作为人类心血管疾病的可调控模型。
Br J Pharmacol. 2022 Mar;179(5):900-917. doi: 10.1111/bph.15473. Epub 2021 May 10.
5
Generation and Application of the Zebrafish Mutant as a Cardiovascular Disease Model.斑马鱼突变体的产生及其在心血管疾病模型中的应用。
Biomolecules. 2020 Nov 12;10(11):1542. doi: 10.3390/biom10111542.
6
Zebrafish heart failure models: opportunities and challenges.斑马鱼心衰模型:机遇与挑战。
Amino Acids. 2018 Jul;50(7):787-798. doi: 10.1007/s00726-018-2578-7. Epub 2018 May 3.
7
Therapeutic Efficacy of Selenium Pre-treatment in Mitigating Cadmium-Induced Cardiotoxicity in Zebrafish (Danio rerio).硒预处理减轻斑马鱼(Danio rerio)镉诱导心脏毒性的治疗效果。
Cardiovasc Toxicol. 2024 Nov;24(11):1287-1300. doi: 10.1007/s12012-024-09910-0. Epub 2024 Aug 30.
8
Evaluation of β-adrenergic ligands for development of pharmacological heart failure and transparency models in zebrafish.评价β-肾上腺素能配体在斑马鱼心脏衰竭和透明模型中的药理学发展。
Toxicol Appl Pharmacol. 2022 Jan 1;434:115812. doi: 10.1016/j.taap.2021.115812. Epub 2021 Nov 26.
9
Zebrafish model of amyloid light chain cardiotoxicity: regeneration versus degeneration.淀粉样轻链心脏毒性的斑马鱼模型:再生与退化
Am J Physiol Heart Circ Physiol. 2019 May 1;316(5):H1158-H1166. doi: 10.1152/ajpheart.00788.2018. Epub 2019 Mar 15.
10
The zebrafish as a tool to identify novel therapies for human cardiovascular disease.斑马鱼作为一种用于识别人类心血管疾病新疗法的工具。
Dis Model Mech. 2014 Jul;7(7):763-7. doi: 10.1242/dmm.016170.

本文引用的文献

1
Metal-Based Nanoparticles for Cardiovascular Diseases.基于金属的纳米粒子在心血管疾病中的应用。
Int J Mol Sci. 2024 Jan 13;25(2):1001. doi: 10.3390/ijms25021001.
2
Natural Allies for Heart Health: Nrf2 Activation and Cardiovascular Disease Management.心脏健康的天然盟友:Nrf2激活与心血管疾病管理
Curr Probl Cardiol. 2024 Jan;49(1 Pt B):102084. doi: 10.1016/j.cpcardiol.2023.102084. Epub 2023 Sep 13.
3
Methyl Parathion Exposure Induces Development Toxicity and Cardiotoxicity in Zebrafish Embryos.甲基对硫磷暴露会导致斑马鱼胚胎发育毒性和心脏毒性。
Toxics. 2023 Jan 15;11(1):84. doi: 10.3390/toxics11010084.
4
Global trends and regional differences in incidence and mortality of cardiovascular disease, 1990-2019: findings from 2019 global burden of disease study.全球心血管疾病发病率和死亡率的趋势和区域差异,1990-2019 年:来自 2019 年全球疾病负担研究的发现。
Eur J Prev Cardiol. 2023 Feb 14;30(3):276-286. doi: 10.1093/eurjpc/zwac285.
5
Impact of pharmaceutical products on zebrafish: An effective tool to assess aquatic pollution.药品对斑马鱼的影响:评估水环境污染的有效工具。
Comp Biochem Physiol C Toxicol Pharmacol. 2022 Nov;261:109439. doi: 10.1016/j.cbpc.2022.109439. Epub 2022 Aug 9.
6
Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: US Preventive Services Task Force Recommendation Statement.促进成年人心血管疾病预防的健康饮食和身体活动的行为咨询干预措施:美国预防服务工作组推荐声明。
JAMA. 2022 Jul 26;328(4):367-374. doi: 10.1001/jama.2022.10951.
7
Cardiovascular Risk Factors and Physical Activity for the Prevention of Cardiovascular Diseases in the Elderly.老年人心血管疾病的心血管危险因素和身体活动预防。
Int J Environ Res Public Health. 2021 Dec 25;19(1):207. doi: 10.3390/ijerph19010207.
8
Novel Insights Into the Pathogenesis of Diabetic Cardiomyopathy and Pharmacological Strategies.糖尿病心肌病发病机制的新见解及药理学策略
Front Cardiovasc Med. 2021 Dec 23;8:707336. doi: 10.3389/fcvm.2021.707336. eCollection 2021.
9
Management of inflammation in cardiovascular diseases.心血管疾病中的炎症管理。
Pharmacol Res. 2021 Nov;173:105912. doi: 10.1016/j.phrs.2021.105912. Epub 2021 Sep 23.
10
Endothelial Dysfunction and Cardiovascular Disease: History and Analysis of the Clinical Utility of the Relationship.内皮功能障碍与心血管疾病:关系的历史及临床应用分析
Biomedicines. 2021 Jun 20;9(6):699. doi: 10.3390/biomedicines9060699.